Best Practice & Research Clinical Haematology

Papers
(The H4-Index of Best Practice & Research Clinical Haematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation67
Contemporary and future strategies in polycythemia vera24
The role of randomized controlled trials, registries, observational databases in evaluating new interventions24
Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes21
Endpoint selection and evaluation in hematology studies21
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALL19
Coagulopathy in COVID-19 and anticoagulation clinical trials19
“The state of the science” of childhood, adolescent and young adult Non Hodgkin Lymphoma (NHL)18
Allogeneic “Off-the-Shelf” CAR T cells: Challenges and advances18
Editorial Board17
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program17
Take a spin: Apheresis in the care of adult leukaemia patients15
Targeted cellular therapy for treatment of relapsed or refractory leukemia14
The presentation of results from studies in clinical haematology14
Vaccine-induced immune thrombotic thrombocytopenia14
0.044258832931519